168 related articles for article (PubMed ID: 28263391)
41. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
[TBL] [Abstract][Full Text] [Related]
42. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
Sheikh MS; Shao ZM; Hussain A; Fontana JA
Cancer Res; 1993 Jul; 53(14):3226-8. PubMed ID: 8324731
[TBL] [Abstract][Full Text] [Related]
43. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
[TBL] [Abstract][Full Text] [Related]
44. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.
Lazennec G; Alcorn JL; Katzenellenbogen BS
Mol Endocrinol; 1999 Jun; 13(6):969-80. PubMed ID: 10379895
[TBL] [Abstract][Full Text] [Related]
45. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
[TBL] [Abstract][Full Text] [Related]
46. Distinct promoter usage of mdm2 gene in human breast cancer.
Okumura N; Saji S; Eguchi H; Nakashima S; Saji S; Hayashi S
Oncol Rep; 2002; 9(3):557-63. PubMed ID: 11956627
[TBL] [Abstract][Full Text] [Related]
47. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer.
Shekhar PV; Chen ML; Werdell J; Heppner GH; Miller FR; Christman JK
Int J Oncol; 1998 Nov; 13(5):907-15. PubMed ID: 9772278
[TBL] [Abstract][Full Text] [Related]
48. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors.
Zhao Y; Che J; Tian A; Zhang G; Xu Y; Li S; Liu S; Wan Y
Curr Cancer Drug Targets; 2022; 22(9):757-770. PubMed ID: 35422219
[TBL] [Abstract][Full Text] [Related]
49. Localization of Pbx1 transcripts in developing rat embryos.
Roberts VJ; van Dijk MA; Murre C
Mech Dev; 1995 Jun; 51(2-3):193-8. PubMed ID: 7547467
[TBL] [Abstract][Full Text] [Related]
50. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.
Carmeci C; Thompson DA; Ring HZ; Francke U; Weigel RJ
Genomics; 1997 Nov; 45(3):607-17. PubMed ID: 9367686
[TBL] [Abstract][Full Text] [Related]
51. PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.
Shah N; Wang J; Selich-Anderson J; Graham G; Siddiqui H; Li X; Khan J; Toretsky J
Clin Cancer Res; 2014 Aug; 20(16):4400-12. PubMed ID: 24947929
[TBL] [Abstract][Full Text] [Related]
52. rs6426881 in the 3'-UTR of PBX1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p.
Mohammadi M; Salehzadeh A; Talesh Sasani S; Tarang A
Mol Biol Rep; 2021 Nov; 48(11):7405-7414. PubMed ID: 34655407
[TBL] [Abstract][Full Text] [Related]
53. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.
Nembrot M; Quintana B; Mordoh J
Biochem Biophys Res Commun; 1990 Jan; 166(2):601-7. PubMed ID: 2302226
[TBL] [Abstract][Full Text] [Related]
54. Expression of the estrogen receptor gene in developing and adult human breast.
Boyd M; Hildebrandt RH; Bartow SA
Breast Cancer Res Treat; 1996; 37(3):243-51. PubMed ID: 8825136
[TBL] [Abstract][Full Text] [Related]
55. Analysis of PBX1 as a candidate gene for type 2 diabetes mellitus in Pima Indians.
Thameem F; Wolford JK; Bogardus C; Prochazka M
Biochim Biophys Acta; 2001 Mar; 1518(1-2):215-20. PubMed ID: 11267683
[TBL] [Abstract][Full Text] [Related]
56. Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
Chimge NO; Ahmed-Alnassar S; Frenkel B
Cell Cycle; 2017 Feb; 16(4):312-318. PubMed ID: 28055379
[TBL] [Abstract][Full Text] [Related]
57. Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation.
Cheung CL; Chan BY; Chan V; Ikegawa S; Kou I; Ngai H; Smith D; Luk KD; Huang QY; Mori S; Sham PC; Kung AW
Hum Mol Genet; 2009 Feb; 18(4):679-87. PubMed ID: 19064610
[TBL] [Abstract][Full Text] [Related]
58. PBX1 is a valuable prognostic biomarker for patients with breast cancer.
Ao X; Ding W; Ge H; Zhang Y; Ding D; Liu Y
Exp Ther Med; 2020 Jul; 20(1):385-394. PubMed ID: 32565927
[TBL] [Abstract][Full Text] [Related]
59. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.
Liu J; Welm B; Boucher KM; Ebbert MT; Bernard PS
Am J Pathol; 2012 Feb; 180(2):839-47. PubMed ID: 22138580
[TBL] [Abstract][Full Text] [Related]
60. Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.
Petrini I; Wang Y; Zucali PA; Lee HS; Pham T; Voeller D; Meltzer PS; Giaccone G
Clin Cancer Res; 2013 Apr; 19(8):1960-71. PubMed ID: 23444221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
